Screening for proteinuria in patients with lupus: A survey of practice preferences among American rheumatologists

Journal of Rheumatology

Volumn 34, Issue 5, 2007, Pages 973-977

  Siedner, Mark J ^a   Christopher Stine, Lisa ^a   Astor, Brad C ^b   Gelber, Allan C ^a   Fine, Derek M ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Johns Hopkins School of Public Health ^*  (United States)

Author keywords

Lupus nephritis; Practice guidelines; Proteinuria; Screening

Indexed keywords

CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; NORMAL HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REVIEW; SCREENING; URINALYSIS;

CREATININE; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROTEINURIA; QUESTIONNAIRES; REAGENT KITS, DIAGNOSTIC; RHEUMATOLOGY; URINALYSIS;

EID: 34248670664     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Cameron J. Lupus nephritis. J Am Soc Nephrol 1999;10:413-24.
2. Cervera RKM, Sebastiani F, Gil A, et al. European Working Party on Systemic Lupus Erythematosus: Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison study of early and late manifestations in a cohort of 1,000 patients. Medicine Baltimore 2003;82:299-308.
3. Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP. The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 1994;21:2046-51.
4. Balow JE. Clinical presentation and monitoring of lupus nephritis. Lupus 2005;14:25-30.
5. Fine DM. Pharmacological therapy of lupus nephritis. JAMA 2005;293:3053-60.
6. Symmons DP, Coppock JS, Bacon PA, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med 1988;69:927-37.
7. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
8. Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988;31:817-25.
9. Meyer NL, Mercer BM, Friedman SA, Sibai BM. Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am J Obstet Gynecol 1994;170:137-41.
10. Garcia C, Bordier L, Burnat P, et al. Urinary dipsticks must not be used to detect diabetes-induced incipient nephropathy [French]. Presse Med 2006;35:1117-21.
11. Gangaram R, Ojwang PJ, Moodley J, Maharaj D. The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy. Hypertens Pregnancy 2005;24:117-23.
12. Zeller A, Sigle JP, Battegay E, Martina B. Value of a standard urinary dipstick test for detecting microalbuminuria in patients with newly diagnosed hypertension. Swiss Med Wkly 2005;135:57-61.
13. Abitbol C, Zilleruelo G, Freundlich M, Strauss J. Quantitation of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic children. J Pediatr 1990;116:243-7.
14. Gai M, Motta D, Giunti S, et al. Comparison between 24-h proteinuria, urinary protein/creatinine ratio and dipstick test in patients with nephropathy: patterns of proteinuria in dipstick-negative patients. Scand J Clin Lab Invest 2006;66:299-307.
15. Waugh JJ, Clark TJ, Divakaran TG, Khan KS, Kilby MD. Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol 2004;103:769-77.
16. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006;54:421-32.
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. 2002; Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. [Internet. Accessed February 19, 2007] Available from: http://www.kidney.org/professionals/ kdoqi/guidelines_ckd/toc.htm
18. Simerville J, Maxted W, Pahira J. Asymptomatic proteinuria is associated with significant renal disease in less than 1.5 percent of patients. Am Fam Physician 2005;71:1153-62.
19. Christopher-Stine L, Siedner M, Lin J, et al. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 2007;34:332-5.